Tumor hypoxia: Chicken, egg, or a piece of the farm?

Journal of Clinical Oncology

Volumn 20, Issue 3, 2002, Pages 610-615

  Coleman, C Norman ^a   Mitchell, James B ^a   Camphausen, Kevin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HYPERBARIC OXYGEN; HYPOXIA; OXYGEN TRANSPORT; PRIORITY JOURNAL; TISSUE OXYGENATION; TUMOR BLOOD FLOW; TUMOR CELL; UTERINE CERVIX CARCINOMA;

EID: 0036467999     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.3.610     Document Type: Editorial

References (71)

1. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer
2. Radiation modifiers
3. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
4. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas
5. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers
6. Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity
7. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects
8. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
9. Pancreatic tumors show high levels of hypoxia
10. Changes in oxygenation during radiotherapy in carcinoma of the cervix
11. Changes in tumor oxygenation during combined treatment with split-course radiotherapy and chemotherapy in patients with head and neck cancer
12. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography
13. Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon
14. Oxygenation of head and neck cancer: Changes during radiotherapy and impact on treatment outcome
15. HIF-1: Using two hands to flip the angiogenic switch
16. Structural and functional analysis of hypoxia-inducible factor 1
17. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia
18. J Transcriptional response to hypoxia in human tumors
19. Hif-1-dependent regulation of hypoxic induction of the cell death factors bnip3 and nix in human tumors
20. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2 alpha
21. Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2
22. HIF-1alpha-mediated upregulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis
23. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo
24. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/ phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics
25. Cancer: Many vessels, faulty gene
26. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
27. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
28. Signal transduction: How do cells sense oxygen?
29. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
30. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
31. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth
32. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
33. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines
34. Suppression of tumor growth through disruption of hypoxia-inducible transcription
35. Targeting tumors through the HIF system
36. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment
37. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor
38. Diffusion limited hypoxia estimated by vascular image analysis: Comparison with pimonidazole staining in human tumors
39. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma
40. Semiquantitative immunohistochemical analysis for hypoxia in human tumors
41. Hypoxia alters iron-regulatory protein- 1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells
42. Iron regulatory proteins, iron responsive elements and iron homeostasis
43. Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p 53 mutations
44. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
45. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization
46. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy
47. Hypoxia and drug resistance
48. Measurement of tumor oxygenation: In vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the p 22 tumor
49. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA 1112 tumors
50. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix
51. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation
52. Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1
53. Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration
54. Detection of hypoxia in human squamous cell carcinoma by EF 5 binding
55. Candidate genes for the hypoxic tumor phenotype
56. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
57. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density
58. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix
59. Hypoxia-inducible expression of tumor-associated carbonic anhydrases
60. Anemia, hypoxia and transfusion in patients with cervix cancer: A review
61. A phase I study of RSR13, a radiation-enhancing hemoglobin modifier: Tolerance of repeated intravenous doses and correlation of pharmacokinetics with pharmacodynamics
62. Initial stages of tumor cell-induced angiogenesis: Evaluation via skin window chambers in rodent models
63. Incipient angiogenesis
64. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
65. Radiation therapy to a primary tumor accelerates metastatic growth in mice
66. Targeting tumor blood vessels: An adjuvant strategy for radiation therapy
67. The effect of local control on metastatic dissemination in carcinoma of the prostate: Long-term results in patients treated with 125I implantation
68. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements
69. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers
70. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-andneck cancer